KEAP1 Antikörper (C-Term)
Kurzübersicht für KEAP1 Antikörper (C-Term) (ABIN4889301)
Target
Alle KEAP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with KEAP1 from human, pig, guinea pig, sheep and other species (due to 100 % sequence homology)
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Synthetic peptide of derived from C terminal part of human KEAP1.
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB(1:500 - 1:200) ICC/ IF(1:200 - 1:1000) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Short term storage at+4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 6 months
-
-
- KEAP1 (Kelch-Like ECH-Associated Protein 1 (KEAP1))
-
Andere Bezeichnung
- KEAP1
-
Hintergrund
- Acts as a substrate adapter protein for the E3 ubiquitin ligase complex formed by CUL3 and RBX1 and targets NFE2L2/NRF2 for ubiquitination and degradation by the proteasome, thus resulting in the suppression of its transcriptional activity and the repression of antioxidant response element-mediated detoxifying enzyme gene expression. Retains NFE2L2/NRF2 and may also retain BPTF in the cytosol. Targets PGAM5 for ubiquitination and degradation by the proteasome.
-
Gen-ID
- 9817
-
UniProt
- Q14145
-
Pathways
- Maintenance of Protein Location
Target
-